Effect of Capivasertib on ctDNA in ER Positive Breast Cancer

Clinical trial NCT06613516 · WITHDRAWN

Trial details

NCT number: NCT06613516
Sponsor: Imperial College London
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Oestrogen Receptor Positive Breast Cancer

Start date: 2025-02-01
Primary completion: 2025-09-16
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.